Latest Breaking News On - Kaitai capital - Page 3 : comparemela.com

China Digest: Cure Genetics nets $60m; Atom Bioscience raises over $47m

China-based biotech startup Cure Genetics and pharmaceutical firm Atom Bioscience have raised new funding.

Boehringer ingelheimBlue ocean capital groupSino ocean groupChina oriza holdingsAscendin fundCure geneticsAtom bioscienceOriza holdingsQiming venture partnersChina renaissanceAdeno associated virusQiming led seriesSong capitalHong kong listedJiangsu atom bioscienceBeijing based kingray capital

HealthCare com raises $180M and other NYC tech news - New York Business Journal

HealthCare com raises $180M and other NYC tech news - New York Business Journal
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLong beachCity ofUnited kingdomSebastjan trepcaHenry wardAnnie kadavyLinda ventrescaBrian laibowCaetano reise sousaYi chun chenBlockchain coinvestorsChristy fletcherSilicon valley bankFounders fund

Legend Capital leads ForQaly Medical s Series B financing

HONG KONG, Oct 8, 2021 - (ACN Newswire) - ForQaly Medical (hereinafter referred to as "ForQaly"), located in Shanghai Zhangjiang International Medical Zone, is a leading high-tech company focused on developing

Joe zhouKostenloser wertpapierhandelChengwei chuangbanTang zhirongShanghai zhangjiang international medical zoneHorizon healthBrain healthQaly medicalLegend capitalLilly asia venturesKaitai capitalManaging directorForqaly medicalKingmed diagnosticsBerry genomicsCareray digital medical

Business Scoop » Legend Capital Leads ForQaly Medical s Series B Financing

Business Scoop provides news and views on Business and Markets from New Zealand

Joe zhouChengwei chuangbanTang zhirongShanghai zhangjiang international medical zoneHorizon healthBrain healthPress releaseForqaly medicalLegend capitalLilly asia venturesKaitai capitalManaging directorKingmed diagnosticsBerry genomicsCareray digital medicalNew horizon health

LAV leads $50m Series B funding in Chinese drug maker Link Pharmaceuticals

New investors New Alliance Capital and Hangzhou Heda Industry Fund participated in the funding round.

United statesTing fengZheshang groupLynk pharmaceuticals coLynk pharmaceuticalsValliance capitalHangzhou heda industry fundLilly asia venturesNew alliance capitalLegend capitalMed fine capitalEast chinaKaitai capitalSinopharm capital